Resource Filter: 1-5
The Combination of ACT and INDUKINE™ Therapy Leads to Improved Antitumor Immunity in Mouse Solid Tumors
Date
Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer
Date
Optimal Antitumor Immunity is Triggered by WTX-124, a Clinical Stage Conditionally Activated INDUKINE™ Molecule that Releases Fully Potent IL-2 into the Tumor Microenvironment
Date
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas
Date
Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis
Date
Macrophage-endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa
Date
Automation of Proximity Ligation Immunoassay for interaction between PD-L1 and PD-1 detection in the tumor microenvironment using microfluidic-based systems
Date
Development of a multiplex test for predicting response to combined immunotherapies in patients with metastatic melanoma
Date
Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling
Date
Microfluidic-based immunohistochemistry combined with next-generation sequencing on diagnostic tissue sections for detection of tumoral BRAF V600E mutation
Date